Differences in endothelial function amongst Sitagliptin and Liraglutide Users: A randomized, open-label, parallel-group and active controlled trial
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Sep 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health,NCT01785043).
- 05 Feb 2013 Planned end date changed from 15 May 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.